2m 2m 2m 2m 2m 2m 2m
REVOLUTION MEDIC (RVMD)
NASDAQ
$169.37+$3.56 (+2.15%)
Price as of Jun 23, 2026 5:21 PM EDT- $35.3BMarket Cap
- 314.11%1-Year Change
- BiotechnologyIndustry
REVOLUTION MEDIC (RVMD)
$169.37+$3.56 (+2.15%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 N/A | 0 -100.00% | 11.6M -67.27% | 35.4M +20.38% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 -100.00% | 11.6M -67.27% | 35.4M +20.38% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -987.3M +66.72% | -592.2M +39.96% | -423.1M -267.20% | 253.1M +35.37% | |
Depreciation and Amortization Expense | 870,000 -18.62% | 1.1M +0.09% | 1.1M -0.09% | 1.1M 0.00% | |
Total Operating Expenses | 1.2B +71.48% | 689.5M +38.25% | 498.8M +69.84% | 293.7M +35.08% | |
Operating Profit | -1.2B +71.48% | -689.5M +41.53% | -487.2M +88.63% | -258.3M +37.38% | |
Interest Income | 90.7M +4.39% | 86.9M +82.98% | 47.5M +418.70% | 9.2M +885.36% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | 0 +100.00% | |
Interest Income and Expense and Net | 90.7M +4.39% | 86.9M +82.98% | 47.5M +418.70% | 9.2M +885.36% | |
Total Nonoperating Income and Expense | 51.1M -42.41% | 88.7M +87.50% | 47.3M +416.65% | 9.2M +898.26% | |
Income before Taxes | -1.1B +88.28% | -600.8M +36.59% | -439.9M +76.57% | -249.1M +33.16% | |
Income Taxes | 0 +100.00% | -753,000 -78.63% | -3.5M +739.05% | -420,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -1.1B +88.52% | -600.1M +37.52% | -436.4M +75.46% | -248.7M +32.93% | |
Net Income from Continuing Operations Applicable to Common | -1.1B +88.28% | -600.8M +36.59% | -439.9M +76.87% | -248.7M +32.93% | |
Basic EPS and Net Income | -5.95 +66.20% | -3.58 -7.25% | -3.86 +25.32% | -3.08 +19.84% | |
Diluted EPS and Net Income | -5.95 +66.20% | -3.58 -7.25% | -3.86 +25.32% | -3.08 +19.84% | |
Basic Weighted Average Shares | 190.1M +13.35% | 167.7M +48.24% | 113.1M +40.34% | 80.6M +10.74% | |
Diluted Weighted Average Shares | 190.1M +13.35% | 167.7M +48.24% | 113.1M +40.34% | 80.6M +10.74% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 383.7M -29.34% | 543.1M -21.99% | 696.1M +331.29% | 161.4M +48.77% | |
Short-Term Investments | 1.6B -5.97% | 1.7B +50.95% | 1.2B +139.24% | 483.5M +3.20% | |
Cash and Cash Equivalents and Short-Term Investments | 2.0B -11.52% | 2.3B +23.55% | 1.9B +187.31% | 644.9M +11.76% | |
Total Current Assets | 2.1B -10.85% | 2.3B +23.86% | 1.9B +184.66% | 660.2M +11.94% | |
Accumulated Depreciation | 28.5M +30.66% | 21.8M +23.34% | 17.7M +22.12% | 14.5M +34.01% | |
Property and Plant and Equipment and Net | 33.2M +36.66% | 24.3M +6.23% | 22.9M +22.54% | 18.7M +61.63% | |
Total Long-Term Assets | 14.8M +6.55% | 13.9M +97.24% | 7.0M +146.13% | 2.9M +276.91% | |
Total Assets | 2.4B -7.97% | 2.6B +24.09% | 2.1B +153.93% | 811.9M +10.02% | |
Income Taxes Payable | 2.4M 0.00% | 2.4M -24.46% | 3.1M -55.66% | 7.0M -5.63% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 290.4M +77.18% | 163.9M +13.95% | 143.9M +132.08% | 62.0M +2.71% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.2M +80.30% | 670,000 -54.05% | 1.5M +384.39% | 301,000 -52.52% | |
Total Liabilities | 723.2M +146.75% | 293.1M +24.45% | 235.5M +85.82% | 126.7M -6.41% | |
Retained Earnings | -2.9B +65.10% | -1.7B +52.75% | -1.1B +62.22% | -701.3M +54.95% | |
Total Stockholders Equity | 1.6B -27.98% | 2.3B +24.04% | 1.8B +166.52% | 685.2M +13.71% | |
Total Shares Outstanding | 197.0M +5.97% | 185.9M +12.89% | 164.7M +82.14% | 90.4M +21.94% | |
Cash Flow | |||||
Cash from Operating Activities | -897.7M +61.05% | -557.4M +59.01% | -350.6M +56.23% | -224.4M +52.47% | |
Capital Expenditures | 16.0M +55.12% | 10.3M +33.37% | 7.7M -28.54% | 10.8M +65.69% | |
Cash from Investing Activities | 118.1M +121.29% | -554.4M +61.82% | -342.6M +1,320.63% | -24.1M -83.03% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 621.5M -35.22% | 959.4M -21.95% | 1.2B +307.79% | 301.4M +2.47% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | -4,207.12% +476.31% | -730.01% +14.12% | |
Return on Assets | -46.06% +77.29% | -25.98% -14.46% | -30.37% -5.37% | -32.09% +11.96% | |
Return on Equity | -58.07% +97.95% | -29.33% -15.59% | -34.75% -10.03% | -38.63% +11.20% | |
Revenue Growth | N/A N/A | -100.00% +48.66% | -67.27% -430.06% | 20.38% +164.45% | |
Current Ratio | 7.14 -49.68% | 14.20 +8.70% | 13.06 +22.66% | 10.65 +8.99% | |
Cash Ratio | 1.32 -60.12% | 3.31 -31.54% | 4.84 +85.84% | 2.60 +44.85% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow